last minute “data-mce-href =” https://www.ntv.com.tr/son-dakika “> Breaking news!
Made in Turkey Sinovac owned by the company CoronaVac Phase-3 results of the vaccine have been announced.
According to the phase 3 results of Hacettepe University, Sinovac The effectiveness of the vaccine was announced as 83.5 percent.
The rate of vaccine preventing hospitalization was found to be 100 percent.
MOST VISITED SIDE EFFECTS
The statement also included the most common side effects after vaccination.
It was stated that fatigue (9.8 percent), headache (7.6 percent) muscle pain (3.8 percent) fever (2.5 percent) chills (2.4 percent) and the most common local side effects were pain at the injection site. .
The vaccine began to be implemented on January 14 in Turkey.